Social Media Ideas for Eli Lilly And Company

<![CDATA[Eli Lilly and Abbisko Announce Drug Development Collaboration]]>

<![CDATA[Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration]]>

<![CDATA[Eli Lilly Enters Three Separate Acquisitions Totaling $3.83 Billion ]]>

<![CDATA[AlzeCure Enters $1 Billion Collaboration and Out-Licensing Agreement with Eli Lilly ]]>

Here’s What the Street is Saying About Eli Lilly and Company (LLY)

Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro

The efficacy of Eli Lilly's new, still-in-development GLP-1 drug is gaining attention, but don't forget its older GLP-1 drugs just yet.

Eli Lilly Wins Court Order in Fraud Allegations Against Florida, TN Pharmacy Groups

Eli Lilly, one of the world’s largest pharmaceutical makers, has won a federal court order against leaders of a Tennessee church and Florida and Tennessee-based pharmacy groups, af...

Here’s What the Street Thinks About Eli Lilly and Company (LLY)

Eli Lilly Conspiracy Claim In Compound Drug Row Challenged

A California federal court should toss part of Eli Lilly's third attempt at allegations that a telehealth company, provider group and a now-shuttered pharmacy conspired to falsely...

Lilly buys non-opioid pain drugmaker 4E

It’s the latest in a string of deals for Lilly, which has sunk more than $18 billion into acquisitions over the past few years.

<![CDATA[Ascidian and Eli Lilly Enter $1.9 Billion Global Research Collaboration to Develop RNA Exon Editors]]>

Why Eli Lilly Gained 7% On Friday

With ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity race

Eli Lilly emerged as the “clear winner from ADA,” according to RBC Capital Markets analyst Trung Hyunh, who added that “the field is getting more crowded—but Lilly is widening its...

CVS obesity drug deal puts Lilly on equal footing with Novo

The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk. 

<![CDATA[Eli Lilly to Deny 340B Drug Pricing Due to Claims-Data Policy: Report ]]>

May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion

May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion admin Tue, 05/26/2026 - 11:55 Lilly keeps pushing forward with deals and pipeline mome...

Eli Lilly stock extends rally as ACHIEVE-3 trial boosts Foundayo outlook

Eli Lilly reunites with Abbisko in $1.9B, multiple target R&D pact

Eli Lilly has expanded its relationship with Abbisko Therapeutics, committing up to $1.9 billion to get the Chinese biotech to apply its drug discovery and early development capabi...

Eli Lilly stock rises after late-stage trial of next-generation weight-loss drug

Eli Lilly shares gained on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.

Lilly snaps up Engage to advance non-viral genetic medicines

The acquisition is Lilly’s latest push into genetic medicine, giving it a technology designed to overcome some of the field’s longstanding limitations.

How to Buy Eli Lilly Stock (LLY)

Pharmaceuticals and the stock market may seem like two completely different worlds to beginner investors, but Eli Lilly and Company proves otherwise. Its stock has delivered exc...

<![CDATA[Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report ]]&g...